Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting

Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1097/MD.0000000000013636
P932PMC publication ID6320035
P698PubMed publication ID30558054

P2093author name stringMimi Kim
Dae Won Jun
Sang Bong Ahn
Bo-Kyeong Kang
Eunwoo Nam
Misoo Chang
P2860cites workNon-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopyQ30441653
Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modelingQ33453637
Correlation between liver histology and novel magnetic resonance imaging in adult patients with non-alcoholic fatty liver disease - MRI accurately quantifies hepatic steatosis in NAFLDQ36219404
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trialsQ36762917
Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric PatientsQ37409370
Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From Adults With Nonalcoholic SteatohepatitisQ38721038
Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver DiseaseQ40444861
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography.Q41042091
Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.Q42270258
Controlled attenuation parameter for non-invasive assessment of hepatic steatosis: does etiology affect performance?Q45206614
Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.Q51714520
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastographyQ57735439
Determination of reliability criteria for liver stiffness evaluation by transient elastographyQ59352739
Liver stiffness measurement using XL probe in patients with nonalcoholic fatty liver diseaseQ87406034
P433issue50
P407language of work or nameEnglishQ1860
P304page(s)e13636
P577publication date2018-12-01
P1433published inMedicineQ15716652
P1476titleOptimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting
P478volume97

Reverse relations

Q64074380Randomized, Double-blind, Placebo-controlled Study of a Multispecies Probiotic Mixture in Nonalcoholic Fatty Liver Diseasecites workP2860

Search more.